TETRAPHASE PHARMACEUTICALS I

CUSIP: 88165N204 Class: COM NEW

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q2 2020
Shares 69,402 Value ($000) $175 Avg Close — Range —
Q1 2020
Shares 40,220 Value ($000) $52 Avg Close — Range —
Q4 2019
Shares 40,220 Value ($000) $113 Avg Close — Range —
Q3 2019
Shares 106,888 Value ($000) $568 Avg Close — Range —